|
|
Volumn 12, Issue 1, 2018, Pages 5-6
|
|
Inflammation and atherosclerosis: fulfilling Koch’s postulates
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIHYPERTENSIVE AGENT;
C REACTIVE PROTEIN;
CANAKINUMAB;
CELL ADHESION MOLECULE;
CHEMOKINE;
CYTOKINE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
HYPOCHOLESTEROLEMIC AGENT;
MONOCLONAL ANTIBODY;
PLACEBO;
ANTIINFLAMMATORY AGENT;
AUTACOID;
BIOLOGICAL MARKER;
LIPID;
ANTIINFLAMMATORY ACTIVITY;
ATHEROGENESIS;
ATHEROSCLEROSIS;
CARDIOVASCULAR DISEASE;
DRUG MECHANISM;
EDITORIAL;
HUMAN;
INFLAMMATION;
NONHUMAN;
PRIORITY JOURNAL;
BLOOD;
MORTALITY;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
TREATMENT OUTCOME;
ANTI-INFLAMMATORY AGENTS;
ANTIBODIES, MONOCLONAL;
ATHEROSCLEROSIS;
BIOMARKERS;
HUMANS;
INFLAMMATION;
INFLAMMATION MEDIATORS;
LIPIDS;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
TREATMENT OUTCOME;
|
|
EID: 85038909008
PISSN: 17539447
EISSN: 17539455
Source Type: Journal
DOI: 10.1177/1753944717744740 Document Type: Editorial |
|
Times cited : (5)
|
|
References (8)
|
